https://www.idival.org/wp-content/uploads/2022/05/cab-presentacion.jpg

A Device That Improves the Experience of Patients With Multiple Myeloma, Assessed in a Study With Participation From IDIVAL

14 de July de 2025

Nurses Nuria Sánchez and Paula Calvo, from the Clinical Trials Unit of the Marqués de Valdecilla University Hospital (HUMV/IDIVAL), have participated in an international study conducted within the framework of a clinical trial led by the Hematology Department. The results have just been published, providing the nursing staff’s perspective on a new drug delivery device […]

Read more →

The ‘Luchamos por la Vida’ Association donates €20,000 to IDIVAL for aggressive breast cancer research

8 de July de 2025

The donation is the result of the 15th edition of their solidarity event held in Los Corrales de Buelna, which brought together thousands of people in support of biomedical research in Cantabria. The Marqués de Valdecilla Research Institute (IDIVAL) received a €20,000 donation from the ‘Luchamos por la Vida’ Association, aimed at supporting a research […]

Read more →

IDIVAL’s Board of Trustees Approves Annual Accounts and Consolidates Its Growth as a Benchmark in Biomedical Research

7 de July de 2025

The Board of Trustees of the Marqués de Valdecilla Research Institute Foundation (IDIVAL) has approved its annual accounts for the 2024 financial year, confirming the institution’s financial stability and soundness. The meeting, held at the Government Pavilion of the University of Cantabria, also provided an opportunity to review a year marked by continuous growth in […]

Read more →

IDIVAL allocates over €460,000 to its research groups to boost scientific output in Cantabria

4 de July de 2025

The Marqués de Valdecilla Research Institute (IDIVAL) has allocated €465,000 this year to support the activity of the 30 research groups that make up the institute. This amount represents a significant increase compared to previous calls and is part of the Support program, which provides backing for the development of activities by IDIVAL’s research groups. […]

Read more →

IDIVAL researchers identify the key role of a neuropeptide in the gut-brain connection

3 de July de 2025

The Clinical and Translational Research Group in Digestive Diseases at the Marqués de Valdecilla Research Institute (IDIVAL) has just published an article in the Revista Española de Enfermedades Digestivas, reviewing and updating current knowledge on the calcitonin gene-related peptide (CGRP) and its role in the bidirectional communication between the central nervous system and the gastrointestinal […]

Read more →

IDIVAL, the Regional Ministry of Health, and the Cantabrian Health Service present progress on health equity and smoking cessation at the Regional Health Congress in Comillas

30 de June de 2025

During the Regional Health Congress held in Comillas (Cantabria), two projects developed within the framework of the Joint Action PreventNCD were presented, focusing on health equity and approaches to tackling smoking. As part of Work Package 7 (WP7), professionals from the Marqués de Valdecilla University Hospital (HUMV) and the Marqués de Valdecilla Research Institute (IDIVAL) […]

Read more →

IDIVAL joins the new eCAN Plus Joint Action to drive digitalisation in European cancer care

26 de June de 2025

The Marqués de Valdecilla Research Institute (IDIVAL) has joined this European initiative through its Medical Oncology and Hematologic Neoplasms and Hematopoietic Stem Cell Transplant teams, following their participation in the previous eCAN Joint Action. The new eCAN Plus Joint Action, officially launched this month in Brussels, aims to improve cancer prevention and care across Europe […]

Read more →

IDIVAL awards the “Prize for International Trajectory in the Protection of the Right to Health” to Professor Rafael Yuste

25 de June de 2025

On 24 June 2025, the Regional Minister of Health of the Government of Cantabria, César Pascual, presented the Award for International Trajectory in the Protection of the Right to Health to Professor Rafael Yuste Rojas, recognised as a ‘figure of international research relevance’. This award, promoted by the Regional Ministry of Health through the Health […]

Read more →

María Muñoz, IDIVAL researcher, wins the Cajal Award in Neurology for a project on multiple sclerosis

Researcher María Muñoz San Martín, from the Marqués de Valdecilla Research Institute (IDIVAL), has been awarded the Cajal Award in the Neurology category in the first edition of these recognitions, promoted by Merck and the Autonomous University of Madrid (UAM) through its Chair of Innovation in Science and Health. The award ceremony took place on […]

Read more →

A Multicenter Study Led by IDIVAL Analyzes the Incidence of Opportunistic Infections in Patients with Autoimmune Hepatitis

24 de June de 2025

Researchers from the Clinical and Translational Research Group in Digestive Diseases at the Marqués de Valdecilla Research Institute (IDIVAL) have coordinated a national multicenter study that, for the first time, analyzes the incidence of opportunistic infections in patients with autoimmune hepatitis. The results, recently published in Alimentary Pharmacology & Therapeutics, confirm that these types of […]

Read more →